RxDoctor Payments Data

Matthew Rupert, MD

Interventional Pain Medicine · Franklin, TNNPI 1124012950

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 44.5% of the total. Reporting peaked in 2023 at $9,545 and has fallen 85.6% since, to $1,370 in 2025.

$16,695in general payments, 2019–2025

Across 185 payments — averaging $90.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Saluda Medical Americas, Inc.$7K
  • Boston Scientific$5K
  • Abbott$1K
  • MML US, Inc.$956
  • Medtronic$718
  • SPR Therapeutics, Inc$216
  • plus $891 from 10 others

What the payments were for

  • Consulting fees$8,20049%
  • Travel & lodging$2,70516%
  • Food & beverage$5,70534%
  • Entertainment$640%
  • Other$220%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,695 in reported general payments places this provider in the 85th percentile of 41 interventional pain medicine providers in Tennessee.

See all interventional pain medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$114,026
Medicare patients
102
Services billed
1,137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine42$10,452
Fentanyl35$3,187
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen75$1,439
Tramadol Hcl ErTramadol Hcl13$1,204
Lidocaine14$963
Gabapentin59$647
Oxycodone Hcl25$332
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen39$292
Pregabalin13$201
Tizanidine Hcl32$188
Baclofen14$107
Tramadol Hcl23$82
Cyclobenzaprine Hcl15$43

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Franklin

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →